Tuesday, April 18, 2017 11:51:09 AM
In a straight R/S or S... the value of what you have should be the same afterwards. You just end up with Less or More shares (respectively).
Obviously with the R/S news... the stock price has taken a beating. R/S in many Penny scenarios isn't a good thing... in this situation, many are taking it as an opportunistic move. If the price keeps moving lower... the R/S move may be worthless.
Either way... weigh your risks. I don't think anyone can tell you for sure. I too am looking to POTENTIALLY add more shares. But it really depends on certain factors.
Their trials could also end up a bust and the stock could tank. This just happened to another bio/pharma recently.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM